These are the stocks posting the largest moves before the bell.Market Insiderread more
CNBC's Mike Santoli breaks down the aggressive buying of "sure things" and shunning of cyclical and policy risk.Trading Nationread more
The Iranian Intelligence Ministry held a briefing on Monday where they announced the alleged spies were Iranian citizens but trained by the CIA.World Newsread more
Equifax will pay at least $575 million, and potentially as much as $700 million, to settle allegations over its massive over 2017 data breach, U.S. regulators said in a...Technologyread more
Facebook has seen an increase in the median number of comments, likes and ads clicked by users on the service from January to July, according to Audience Insights, a Facebook...Technologyread more
Two traders say Boeing's on the path to recovery.Trading Nationread more
In its latest attempt to build market credibility, China on Monday launched the Science and Technology Innovation Board, or "STAR Market," on which 25 companies were listed.China Economyread more
Bridgewater Associates's flagship fund reportedly posted one of its worst first-half performances in two decades.Hedge Fundsread more
The U.S. will likely emerge the winner in a "cold currency war" that is heating up, an expert said.Currenciesread more
General Electric is scheduled to report second-quarter earnings at the end of the month.Investingread more
These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Check out the companies making headlines midday Wednesday:
Adobe — Adobe climbed 5.2% after reporting better-than-expected quarterly results. The technology company earned an adjusted $1.83 per share on $2.74 billion in revenue for the fiscal second quarter. Wall Street expected an adjusted earnings per share of $1.78 on $2.70 billion in revenue, according to Refinitiv.
Six Flags Entertainment — Shares of Six Flags Entertainment rose 2% after the amusement company was upgraded to outperform from neutral by Wedbush. The analysts cited a potential rise in customer spending from a membership program, approval of new parks in China and good weather comparisons to last year as reasons for the upgrade. Wedbush now has a target price of $62 per share for the company.
Energizer Holdings — The battery maker's stock dropped 6.3% after J.P. Morgan downgraded it to underweight from neutral. "While the battery category is a relatively stable business … worsening shelf space losses for Rayovac will likely continue to be a headwind to results until at least 3QFY20."
Axalta Coating Systems — Shares of the paint and coating manufacturer surged more than 13% after the company announced it is exploring strategic alternatives to "maximize shareholder value," including a potential sale.
TripAdvisor — TripAdvisor shares climbed 1.9% after an analyst at SunTrust upgraded them to buy from hold, citing an estimated 30% annual growth in the company's "Experiences" segment.
La-Z-Boy — La-Z-Boy shares surged more than 8% as traders shrugged off concerns over the impact of U.S. tariffs on Chinese goods on the furniture maker's bottom line. The company said in its latest quarterly report that additional U.S. tariffs on Chinese products would increase the cost of raw materials, which would force it to raise prices.
Rio Tinto — Rio Tinto's U.S.-listed shares slid 3.7% after the company cut its iron ore production guidance. The company said it expects to produce between 320 million and 330 million tons of iron ore. That's below a previous guidance of 333 million and 343 million tons.
Jabil —Jabil rose 10.3% after the electronics maker issued stronger-than-forecast earnings guidance for the fourth quarter. The company expected earnings to range between 76 cents and 96 cents a share. The top end of the range topped a Refinitiv median estimate of 86 cents a share. Jabil also reported a better-than-expected revenue for its fiscal third quarter.
Allergan —Allergan shares rose 6.2% after the pharmaceutical company reported positive trial results for Linzess, a drug aimed a treating irritable bowel syndrome.